Lessons learned from an M&E task-shifting initiative in Botswana
Results and Lessons Learned from CapacityPlus 2009-2015
HIV Testing and Counselling Guidelines
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
National Tuberculosis and Leprosy Conrol Programme
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition